Table 4 Virulence genes and genetic profile of Salmonella spp. isolates from human stool in Burkina Faso
Salmonella Strain code | Ye ar | City | Source | Serotypes | Antigenic formule positive | Identified genes | Genetic profile |
|---|---|---|---|---|---|---|---|
44 | 2018 | Ouagadougou | Human | ICS | OMB+ O:6,7,8 | invA, fimA, stn, spvR, spvC | P1 |
45 | 2018 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvR, spvC | P1 |
46 | 2018 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMB Hgm | invA, fimA, stn, spvR, spvC | P1 |
48 | 2018 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi | invA, fimA, stn, spvR, spvC | P1 |
50 | 2018 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMB Hg | invA, fimA, stn, spvR, spvC | P1 |
51 | 2018 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB Hg | invA, fimA, stn, spvR, spvC | P1 |
53 | 2018 | Ouagadougou | Human | Typhimurium | OMA+ O:4,5; HMA Hi; H1H2 | invA, fimA, stn, spvR, spvC | P1 |
59 | 2017 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvR, spvC | P1 |
68 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB Hg | invA, fimA, stn, spvR, spvC | P1 |
71 | 2018 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvR, spvC | P1 |
74 | 2017 | Koudougou | Human | Enteritidis | OMA+ O:9; HMB Hgm | invA, fimA, stn, spvR, spvC | P1 |
75 | 2017 | Koudougou | Human | Enteritidis | OMA+ O:9; HMB Hgm | invA, fimA, stn, spvR, spvC | P1 |
85 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMB Hgm | invA, fimA, stn, spvR, spvC | P1 |
86 | 2017 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvR, spvC | P1 |
3 | 2017 | Bobo-Dioulasso | Human | Enteritidis | OMA+ O:9; HMB Hgm | invA, fimA, stn, spvR, spvC | P1 |
17 | 2017 | Ouagadougou | Human | ICS | OMA+ O:9 | invA, fimA, stn, spvR, spvC | P1 |
18 | 2018 | Ouagadougou | Human | ICS | OMB+ O:6,7,8 | invA, fimA, stn, spvR, spvC | P1 |
19 | 2018 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvR, spvC | P1 |
27 | 2018 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB, Hg | invA, fimA, stn, spvR, spvC | P1 |
28 | 2018 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvR, spvC | P1 |
29 | 2018 | Ouagadougou | Human | Typhimurium | OMA+ O:4,5; HMA Hi; H1H2 | invA, fimA, stn, spvR, spvC | P1 |
30 | 2017 | Ouagadougou | Human | ICS | OMA+ O:3,10,15; HMA Hi | invA, fimA, stn, spvR, spvC | P1 |
32 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMB | invA, fimA, stn, spvR, spvC | P1 |
34 | 2017 | Ouagadougou | Human | ICS | OMA+ O:9 | invA, fimA, stn, spvR, spvC | P1 |
35 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi* | invA, fimA, stn, spvR, spvC | P1 |
36 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi* | invA, fimA, stn, spvR, spvC | P1 |
37 | 2017 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvR, spvC | P1 |
38 | 2017 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvR, spvC | P1 |
39 | 2017 | Ouagadougou | Human | ICS | OMA+ O:9 | invA, fimA, stn, spvR, spvC | P1 |
40 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMA | invA, fimA, stn, spvR, spvC | P1 |
43 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB | invA, fimA, stn, spvR, spvC | P1 |
1 | 2017 | Bobo-Dioulasso | Human | ICS | OMA+ O:4,5; HMB Hg | invA, fimA, stn, spvC | P2 |
4 | 2017 | Bobo-Dioulasso | Human | ICS | OMA+ O:4,5; HMB,Hgm | invA, fimA, stn, spvC | P2 |
20 | 2018 | Ouagadougou | Human | ICS | OMB+ | invA, fimA, stn, spvC | P2 |
21 | 2018 | Ouagadougou | Human | ICS | OMB+ | invA, fimA, stn, spvC | P2 |
22 | 2018 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMB | invA, fimA, stn, spvC | P2 |
23 | 2018 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvC | P2 |
24 | 2018 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvC | P2 |
25 | 2018 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA, stn, spvC | P2 |
26 | 2018 | Ouagadougou | Human | ICS | OMB+ O:6,7,8 | invA, fimA, stn, spvC | P2 |
80 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi* | invA, fimA, stn, spvC | P2 |
81 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi* | invA, fimA, stn, spvC | P2 |
84 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi* | invA, fimA, stn, spvC | P2 |
2 | 2017 | Bobo-Dioulasso | Human | ICS | OMB+ O:6,7,8 | invA, fimA, stn | P3 |
5 | 2017 | Bobo-Dioulasso | Human | ICS | OMB+ | invA, fimA, stn | P3 |
6 | 2017 | Bobo-Dioulasso | Human | ICS | OMB+ O:6,7,8; HMA Hi* | invA, fimA, stn | P3 |
7 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB,Hgm | invA, fimA, stn | P3 |
8 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA | invA, fimA, stn | P3 |
9 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA, Hi* | invA, fimA, stn | P3 |
10 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB,H1 | invA, fimA, stn | P3 |
11 | 2017 | Ouagadougou | Human | ICS | OMB+ | invA, fimA, stn | P3 |
14 | 2017 | Ouagadougou | Human | ICS | OMA+ | invA, fimA, stn | P3 |
15 | 2017 | Ouagadougou | Human | ICS | OMA+ | invA, fimA, stn | P3 |
16 | 2017 | Ouagadougou | Human | ICS | OMA+ O:9 | invA, fimA, stn | P3 |
54 | 2018 | Ouagadougou | Human | ICS | OMB+ | invA, fimA, stn | P3 |
55 | 2018 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB Hg | invA, fimA, stn | P3 |
73 | 2018 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB Hg | invA, fimA, stn | P3 |
72 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8 | fimA, stn, spvC | P4 |
13 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMB | invA, fimA | P5 |
31 | 2017 | Ouagadougou | Human | ICS | OMA-OMB- | invA, fimA | P5 |
33 | 2017 | Ouagadougou | Human | ICS | OMA+ O:3,10,15 | invA, stn | P6 |
58 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMB Hgmb | fimA, stn | P7 |
57 | 2017 | Ouagadougou | Human | Enteritidis | OMA+ O:9; HMB Hgm | fimA, spvR | P8 |
12 | 2017 | Ouagadougou | Human | ICS | OMA+ | invA | P9 |
42 | 2017 | Ouagadougou | Human | ICS | OMA+ O:3,10,15 | fimA | P10 |
56 | 2017 | Ouagadougou | Human | Typhimurium | OMA+ O:4,5; HMA Hi; H1H2 | fimA | P10 |
60 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB Hg | fimA | P10 |
62 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB Hg | fimA | P10 |
63 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMB Hgmc | fimA | P10 |
65 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMA Hi | fimA | P10 |
66 | 2017 | Ouagadougou | Human | ICS | OMB+ | fimA | P10 |
67 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMB Hgm | fimA | P10 |
41 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5, HMB Hgm | … | P11 |
47 | 2018 | Ouagadougou | Human | ICS | OMA-OMB- | … | P11 |
49 | 2018 | Ouagadougou | Human | ICS | OMA+ O:3,10,15 | … | P11 |
52 | 2018 | Ouagadougou | Human | ICS | OMA + O:3,10,15 | … | P11 |
61 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5; HMB | … | P11 |
64 | 2017 | Ouagadougou | Human | ICS | OMA-OMB- | … | P11 |
69 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMB Hgm | … | P11 |
70 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi* | … | P11 |
76 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi* | … | P11 |
77 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi* | … | P11 |
78 | 2017 | Ouagadougou | Human | ICS | OMB+ | … | P11 |
79 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8; HMA Hi* | … | P11 |
82 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5 | … | P11 |
83 | 2017 | Ouagadougou | Human | ICS | OMA+ O:4,5 | … | P11 |
87 | 2017 | Ouagadougou | Human | ICS | OMB+ | … | P11 |
88 | 2017 | Ouagadougou | Human | ICS | OMB+ O:6,7,8 | … | P11 |
89 | 2017 | Ouagadougou | Human | ICS | OMB+ | … | P11 |
90 | 2017 | Ouagadougou | Human | Enteritidis | OMA+ O:9; HMB Hgm | … | P11 |
91 | 2017 | Ouagadougou | Human | ICS | OMB+ | … | P11 |